Abstract
Nicotinamide adenine dinucleotide (NAD + ) metabolism is integrally connected with the mechanisms of action of radiation therapy and is altered in many radiation-resistant tumors. This makes NAD + metabolism an ideal target for therapies that increase radiation sensitivity and improve patient outcomes. This review provides an overview of NAD + metabolism in the context of the cellular response to ionizing radiation, as well as current therapies that target NAD + metabolism to enhance radiation therapy responses. Additionally, we summarize state-of-the-art methods for measuring, modeling, and manipulating NAD + metabolism, which are being used to identify novel targets in the NAD + metabolic network for therapeutic interventions in combination with radiation therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 6-15 |
Number of pages | 10 |
Journal | Seminars in Radiation Oncology |
Volume | 29 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2019 |
ASJC Scopus subject areas
- Oncology
- Radiology Nuclear Medicine and imaging
- Cancer Research